Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > This constant selling...........
View:
Post by ggrellette on May 26, 2022 4:17pm

This constant selling...........

here is becoming long in the tooth. It is also wearing down the most enthusiastic investor.
Comment by Legit62 on May 26, 2022 4:33pm
Patience, we are close, once we get BTD it wont matter, all us longs with substantial shares are holding tight, theres always going to be day traders trying to make a buck, it sucks but we will all be rewarded
Comment by Legit62 on May 26, 2022 4:34pm
Good volume today
Comment by LaserStock29 on May 26, 2022 7:21pm
I remember that was said about fast track Now its BTD Then you apply for Marketing permit which can take months Whoops was that a secret
Comment by Rumpl3StiltSkin on May 27, 2022 8:55am
The great thing about BTD Laser is it is indeed just a few months after to get AA. With FT it can be a longer process and not a done deal...
Comment by LaserStock29 on May 27, 2022 9:25am
Ya if we apply Q4 2022 for BTD and that takes 6 months.. then AA takes what 4months. Your basically end of 2023 Thanks but no thanks. That won't fly at the agm A buyout of technologies is very much a reasonable position at this point And we know pharma influences fda in decision making aka the vaccine right. So if a big pharma paid roger u know they Seinfeld the hammer to get It the rest of ...more  
Comment by ScienceFirst on May 27, 2022 9:37am
Your impatience and how long you've been in the stock won't change anything.  That was up to you to better assess the timelines or go invest elsewhere.  At least, we're still in the game, versus other technologies that went nowhere.  And we could even become the next SOC if data delivers.  So your impatience has no value.  And markets, most of the times, step ...more  
Comment by ScienceFirst on May 27, 2022 9:54am
TLT has identified commercial revenues (projected) starting Jan. 2023.  So I assume they have more info and insights than you. _____________________   LaserStock29 - (5/27/2022 9:25:50 AM) RE:RE:RE:RE:This constant selling........... Ya if we apply Q4 2022 for BTD and that takes 6 months.. then AA takes what 4months. Your basically end of 2023 Thanks but no thanks ...more  
Comment by FGPstock on May 27, 2022 10:00am
Benrco: First, tlt's timelines have never been accurate. Second, if they do actually have commercial revenues slated ffor 1/23, then they are hding very important material information, again...
Comment by Lesalpes29 on May 27, 2022 10:12am
Laurel or Hardy! Who are you?
Comment by FGPstock on May 27, 2022 10:18am
Neither, bencro likes to bash anyone who has an opinion and just tried to belittle Laser buy sayint the company is slated for commercial rev 1/23 and "has more imformation than him" if this is true, we all should know it. Bencro will give you 60 comparisions of Billion dollar buyouts, then when you question the stock @ .30 he will tell you that u either bought too soon or your an idiot.
Comment by ScienceFirst on May 27, 2022 10:23am
FGPstock ... Why would they hide material info when they cannot.  And if you hag read my post correctly, you would have noticed "projected".   Ask yourself why they advanced by 39 months these projected revenues.  
Comment by Lesalpes29 on May 27, 2022 10:26am
L Laurel showing up when the SP could go up! 
Comment by ScienceFirst on May 27, 2022 10:32am
Agree Lesaloes29. FGPstock is back at discrediting TLT and wants people to believe this stock is fairly valued and is not worth it @0.30$, 35% into a Ph.2! ... Lolll
Comment by Lesalpes29 on May 27, 2022 10:43am
Only posting here Laurel... since the big drop at the begging of April. And Laurel is with us since April 4th. Lot of credibility! 
Comment by FGPstock on May 27, 2022 10:58am
Les, if it makes you and bencro feel better bashing me, go right ahead. bencro has had so many alliases it is hard to keep up w his name, i only know him by his demeaning posts. I actually have a wire in to buy more shares today, have been in tlt longer than most and probably own more shares than most. Regardless, that doesn't make my opinion better or worse than anyone elses, it seems some ...more  
Comment by LaserStock29 on May 27, 2022 10:40am
Clarify what the breadth/meaning  of 'Commercial Revenues' entails Starting Jan 2023  Negotiation Mid-End 2022 for to be realized as Commercial Revenue Jan 2023? 1. A buyout of 'Developed IP technology'  TLD-1433 + ACT for NMIBC and Rights to MIBC   2. FDA actually speeds us along with BTD and AA... and we actually get our valuation. Both would ...more  
Comment by enriquesuave on May 27, 2022 11:03am
Commercial Revenues in January 2023 could mean a Partnership Deal after BTD granted?  Hence upfront payment and in preparation for AA application to follow.?  Just guessing.
Comment by Rumpl3StiltSkin on May 27, 2022 11:06am
I think we will get AA early 2nd qtr 2023. Yes Laser. I think that is what they mean by commercial revenues. Selling 1433 to urologists in the US with an, conditionally, FDA approved product. They will likely need some partner for this as they don't currently have the resources to market distribute and manufacture all the different pieces of their ACT. At least not to Scale...
Comment by ScienceFirst on May 27, 2022 12:00pm
Commercial revenues are clearly identified starting Jan.  2023.  Not Q2. Just like Breakthrough designation identified not in December 2022 but early November.  It's striking. So they seem to have received quite clear input to suddenly have advanced those revenues by 30 months.  and be that precise.  
Comment by Eoganacht on May 27, 2022 12:15pm
But Hutchmed, Li Ka-shing's cancer drug company might... Hutchmed was expecting FDA approval for their first anti-cancer drug in the US, surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumours. Instead they got a complete response letter from the FDA on May 2. Hutchmed had built a small US commercialization team in anticipation of approval. So now they have a ...more  
Comment by Rumpl3StiltSkin on May 27, 2022 12:36pm
Excellent point Eoga! ;-)
Comment by ScienceFirst on May 27, 2022 12:38pm
The changes in the corporate presentation have been made on Feb. 7.   So something happened between August 2021 and Feb. 7 2022.  They seem to have had a very constructive meeting with the FDA in August that then led to the hiring of Dr. Vera Madzaveric early October and her statement regarding the Breakthrough designation in the November 29 newsletter.
Comment by ScienceFirst on May 26, 2022 5:09pm
See the game  May 26, 2022 3:58 PM 0.31 - - 500 TSXV Virtu ITG Canada Corp. CIBC World Markets Inc. May 26, 2022 3:58 PM  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250